Cipla

{
  "main_header": {
    "sid": 597145,
    "name": "Cipla",
    "stock_name": "Cipla",
    "full_name": "Cipla Ltd.",
    "name_url": "stocks-analysis/cipla",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,324.00",
    "chg": 12.25,
    "chgp": "0.93%",
    "dir": 1,
    "prev_price": "1,311.75",
    "mcapval": "107,802.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500087,
    "symbol": "CIPLA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE059A01026",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "28.28 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cipla-597145-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cipla Ltd. Technical Momentum Shifts to Bearish Amid Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-technical-momentum-shifts-to-bearish-amid-market-underperformance-3817173",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CiplaLtd_technicaldot_3817173.png",
        "date": "2026-02-03 08:02:22",
        "description": "Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Cipla Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-technical-momentum-shifts-amid-mixed-market-signals-3815390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CiplaLtd_technicaldot_3815390.png",
        "date": "2026-02-02 08:02:53",
        "description": "Cipla Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle yet notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.14%, the stock’s recent downgrade from Hold to Sell by MarketsMOJO on 7 January 2026 highlights growing caution among analysts amid mixed technical indicators and underwhelming relative returns compared to the broader Sensex."
      },
      {
        "title": "Cipla Ltd Faces Headwinds Amid Nifty 50 Membership and Institutional Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-faces-headwinds-amid-nifty-50-membership-and-institutional-shifts-3813865",
        "imagepath": "",
        "date": "2026-02-01 09:20:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Impact</strong></p>\n                <p>As a prominent member of the Nifty 50, Cipla Ltd. holds a significant position in India’s benchmark equity index, which comprises the 50 largest and most liquid stocks listed on the National Stock Exchange. Inclusion in this index not only enhances visibility among domestic and global investors but also ensures substantial passive fund inflows from index-tracking mutual funds and exchange-traded funds (ETFs). Consequently, any change in Cipla’s fundamentals or market perception can have amplified effects on its stock price and trading volumes.</p>\n                <p>However, Cipla’s recent underperformance relative to the broader market has raised concerns. The stock closed at ₹1,347.50, hovering just 4.86% abo..."
      },
      {
        "title": "Cipla Ltd Gains 0.69%: 2 Key Factors Driving the Week’s Mixed Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-gains-069-2-key-factors-driving-the-weeks-mixed-performance-3813084",
        "imagepath": "",
        "date": "2026-01-31 16:09:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Cipla hits 52-week low of Rs.1,283 amid continued downtrend</p>\n                    <p><strong>27 Jan:</strong> Reports sharp 35.0% decline in quarterly PAT, signalling negative financial trend</p>\n                    <p><strong>30 Jan:</strong> Week closes at Rs.1,323.95, up 0.69% for the week but underperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,314.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,323.95</div><div class=\"stat-change pos..."
      },
      {
        "title": "Cipla Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cipla-ltd-is-rated-sell-by-marketsmojo-3811205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CiplaLtd_mojoScore_3811205.png",
        "date": "2026-01-30 10:10:03",
        "description": "Cipla Ltd. is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. While the rating change occurred earlier this month, the analysis and financial metrics discussed here reflect the stock's present condition as of 30 January 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Cipla Ltd: Navigating Challenges Amidst Nifty 50 Membership and Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-amidst-nifty-50-membership-and-sector-dynamics-3810791",
        "imagepath": "",
        "date": "2026-01-30 09:20:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable visibility and liquidity advantages to Cipla Ltd., attracting a broad spectrum of institutional investors and index funds. This membership not only enhances the stock’s trading volumes but also integrates it into numerous passive investment strategies, thereby amplifying its market impact. However, inclusion also subjects Cipla to heightened scrutiny and performance expectations, especially as the index serves as a barometer for India’s blue-chip equities.</p>\n                <p>In the current market environment, Cipla’s position within the Nifty 50 is a double-edged sword. While it benefits from steady institutional inflows, the stock’s recent price action..."
      },
      {
        "title": "Cipla Ltd: Navigating Challenges as a Nifty 50 Pharmaceutical Giant",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-as-a-nifty-50-pharmaceutical-giant-3808936",
        "imagepath": "",
        "date": "2026-01-29 09:20:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable advantages to Cipla Ltd., including enhanced visibility among domestic and international investors and inclusion in numerous index-tracking funds and ETFs. This membership typically supports liquidity and can provide a valuation premium relative to non-index stocks. However, Cipla’s recent performance suggests that index inclusion alone is insufficient to shield it from sectoral and company-specific headwinds.</p>\n                <p>As of 29 Jan 2026, Cipla’s market capitalisation stands at a robust ₹1,06,625.80 crore, affirming its large-cap status. Yet, the stock is trading close to its 52-week low, just 3.52% above the bottom at ₹1,283, signalling invest..."
      },
      {
        "title": "Cipla Ltd: Navigating Challenges as a Nifty 50 Pharmaceutical Giant",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-as-a-nifty-50-pharmaceutical-giant-3806939",
        "imagepath": "",
        "date": "2026-01-28 09:20:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a member of the Nifty 50, Cipla Ltd. holds a prestigious position among India’s blue-chip companies, representing a substantial portion of the market capitalisation and liquidity in the Indian equity markets. Inclusion in this benchmark index not only enhances the stock’s visibility among domestic and international investors but also ensures steady demand from index funds and passive investment vehicles that track the Nifty 50. This status typically provides a degree of price support and stability, as fund managers allocate capital to maintain index weightings.</p>\n                <p>However, Cipla’s recent performance indicates that index membership alone is insufficient to shield it from sectoral and comp..."
      },
      {
        "title": "Cipla Ltd. Stock Falls to 52-Week Low of Rs.1283 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-stock-falls-to-52-week-low-of-rs1283-amidst-continued-downtrend-3805652",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CiplaLtd_priceRelatedfactors_3805652.png",
        "date": "2026-01-27 10:14:08",
        "description": "Cipla Ltd., a key player in the Pharmaceuticals & Biotechnology sector, witnessed its stock price decline to a fresh 52-week low of Rs.1283 on 27 Jan 2026, marking a significant milestone in its recent performance trajectory. The stock has been under pressure, reflecting a series of financial and market factors that have influenced investor sentiment and valuation."
      }
    ],
    "total": 927,
    "sid": "597145",
    "stock_news_url": "https://www.marketsmojo.com/news/cipla-597145"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "28-Jan-2026",
      "details": "In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby notify that the Operations and Administrative Committee of the Company on 28th January 2026 has allotted 8879 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Employee Stock Option Scheme 2013-A and the Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "27-Jan-2026",
      "details": "We are enclosing hereby a copy of the transcript of the Companys Q3 FY26 earning conference call dated 23rd January 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "24-Jan-2026",
      "details": "Please find attached newspaper advertisement",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has declared <strong>650%</strong> dividend, ex-date: 27 Jun 25",
          "dt": "2025-06-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has announced <strong>3:2</strong> bonus issue, ex-date: 24 Apr 06",
          "dt": "2006-04-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Cipla Ltd. Technical Momentum Shifts to Bearish Amid Market Underperformance

2026-02-03 08:02:22

Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling caution for investors amid a challenging market backdrop.

Read full news article

Cipla Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-02-02 08:02:53

Cipla Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle yet notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.14%, the stock’s recent downgrade from Hold to Sell by MarketsMOJO on 7 January 2026 highlights growing caution among analysts amid mixed technical indicators and underwhelming relative returns compared to the broader Sensex.

Read full news article

Cipla Ltd Faces Headwinds Amid Nifty 50 Membership and Institutional Shifts

2026-02-01 09:20:48

Index Membership and Market Impact

As a prominent member of the Nifty 50, Cipla Ltd. holds a significant position in India’s benchmark equity index, which comprises the 50 largest and most liquid stocks listed on the National Stock Exchange. Inclusion in this index not only enhances visibility among domestic and global investors but also ensures substantial passive fund inflows from index-tracking mutual funds and exchange-traded funds (ETFs). Consequently, any change in Cipla’s fundamentals or market perception can have amplified effects on its stock price and trading volumes.

However, Cipla’s recent underperformance relative to the broader market has raised concerns. The stock closed at ₹1,347.50, hovering just 4.86% abo...

Read full news article

Cipla Ltd Gains 0.69%: 2 Key Factors Driving the Week’s Mixed Performance

2026-01-31 16:09:02

Key Events This Week

27 Jan: Cipla hits 52-week low of Rs.1,283 amid continued downtrend

27 Jan: Reports sharp 35.0% decline in quarterly PAT, signalling negative financial trend

30 Jan: Week closes at Rs.1,323.95, up 0.69% for the week but underperforming Sensex

Week Open

Rs.1,314.85

Week Close

Rs.1,323.95

Read full news article

Cipla Ltd. is Rated Sell by MarketsMOJO

2026-01-30 10:10:03

Cipla Ltd. is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. While the rating change occurred earlier this month, the analysis and financial metrics discussed here reflect the stock's present condition as of 30 January 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Read full news article

Cipla Ltd: Navigating Challenges Amidst Nifty 50 Membership and Sector Dynamics

2026-01-30 09:20:58

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable visibility and liquidity advantages to Cipla Ltd., attracting a broad spectrum of institutional investors and index funds. This membership not only enhances the stock’s trading volumes but also integrates it into numerous passive investment strategies, thereby amplifying its market impact. However, inclusion also subjects Cipla to heightened scrutiny and performance expectations, especially as the index serves as a barometer for India’s blue-chip equities.

In the current market environment, Cipla’s position within the Nifty 50 is a double-edged sword. While it benefits from steady institutional inflows, the stock’s recent price action...

Read full news article

Cipla Ltd: Navigating Challenges as a Nifty 50 Pharmaceutical Giant

2026-01-29 09:20:48

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable advantages to Cipla Ltd., including enhanced visibility among domestic and international investors and inclusion in numerous index-tracking funds and ETFs. This membership typically supports liquidity and can provide a valuation premium relative to non-index stocks. However, Cipla’s recent performance suggests that index inclusion alone is insufficient to shield it from sectoral and company-specific headwinds.

As of 29 Jan 2026, Cipla’s market capitalisation stands at a robust ₹1,06,625.80 crore, affirming its large-cap status. Yet, the stock is trading close to its 52-week low, just 3.52% above the bottom at ₹1,283, signalling invest...

Read full news article

Cipla Ltd: Navigating Challenges as a Nifty 50 Pharmaceutical Giant

2026-01-28 09:20:47

Significance of Nifty 50 Membership

As a member of the Nifty 50, Cipla Ltd. holds a prestigious position among India’s blue-chip companies, representing a substantial portion of the market capitalisation and liquidity in the Indian equity markets. Inclusion in this benchmark index not only enhances the stock’s visibility among domestic and international investors but also ensures steady demand from index funds and passive investment vehicles that track the Nifty 50. This status typically provides a degree of price support and stability, as fund managers allocate capital to maintain index weightings.

However, Cipla’s recent performance indicates that index membership alone is insufficient to shield it from sectoral and comp...

Read full news article

Cipla Ltd. Stock Falls to 52-Week Low of Rs.1283 Amidst Continued Downtrend

2026-01-27 10:14:08

Cipla Ltd., a key player in the Pharmaceuticals & Biotechnology sector, witnessed its stock price decline to a fresh 52-week low of Rs.1283 on 27 Jan 2026, marking a significant milestone in its recent performance trajectory. The stock has been under pressure, reflecting a series of financial and market factors that have influenced investor sentiment and valuation.

Read full news article

View All News